secwatch.observer — SEC 8-K summary
======================================

Issuer:     Varex Imaging Corp (VREX)
CIK:        0001681622
Form:       8-K
Filed at:   2024-08-01T23:59:59+00:00
Accession:  0001681622-24-000068
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Varex Q3 FY2024 revenue down 10% YoY; Q4 guidance weak
------------------------------------------------------

- Revenue $209M (-10% YoY); GAAP EPS $0.03, Non-GAAP EPS $0.14 vs $0.37 YoY.
- Medical segment revenue $149M (-15% YoY); Industrial segment $60M (+6% YoY).
- Cash flow from operations $8M; cash and equivalents $192M (flat vs FY2023).
- Q4 FY2024 guidance: revenue $190-210M, Non-GAAP EPS $0.00-$0.15, citing challenging market conditions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1681622/000168162224000068/0001681622-24-000068-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1681622/000168162224000068/vrex-20240801.htm
  HTML page:      https://secwatch.observer/filing/0001681622-24-000068

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer